KOJIMA Junnosuke | Department of Internal Medicine
スポンサーリンク
概要
関連著者
-
KOJIMA Junnosuke
Department of Internal Medicine
-
Inoue Atsuo
Department Of Internal Medicine
-
TANAKA Sachiko
Department of Biochemical Toxicology, School of Pharmacy, Showa University
-
INOUE Atsuo
Department of Radiology, Osaka University Graduate School of Medicine
-
NAKAO Miho
Department of Cancer Survey, Osaka Medical Center for Cancer & CVD
-
Nakao Miho
Department Of Cancer Survey Osaka Medical Center For Cancer & Cvd
-
Nakao Miho
Department Of Gastroenterological Cancer Screening Osaka Medical Center For Cancer And Cardiovascula
-
OSHIMA Akira
Department of Cancer Control and Statistics
-
MATSUNAGA Takashi
The Center for Adult Diseases, Division of Clinical Laboratory
-
KOJIMA Junnosuke
The Center for Adult Diseases, Division of Clinical Laboratory
-
INOUE Atsuo
The Center for Adult Diseases, Division of Clinical Laboratory
-
ARAO Masayo
The Center for Adult Diseases, Division of Clinical Laboratory
-
Inoue Atsuo
Department Of Gastrointestinal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Tsukuma Hideaki
Department Of Cancer Control And Statistics Osaka Medical Center For Cancer And Cardiovascular Disea
-
Arao Masayo
The Center For Adult Diseases Division Of Clinical Laboratory
-
Tanaka Sachiko
Department Of Biochemical Toxicology School Of Pharmacy Showa University
-
Tanaka Sachiko
Department Of Gastroenterological Cancer Screening Osaka Medical Center For Cancer And Cardiovascula
-
Matsunaga Takashi
Department Of Biopharmaceutics Faculty Of Pharmaceutical Sciences Chiba University
-
YABUUCHI Takako
Department of Gastroenterological Cancer Screening, Osaka Medical Center for Cancer and Cardiovascular Diseases
-
INOUE Atsuo
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
著作論文
- Effectiveness of Interferon Therapy for Reducing the Incidence of Hepatocellular Carcinoma among Patients with Type C Chronic Hepatitis
- Prediction of sustained response to interferon alpha therapy with serum soluble interleukin 2 receptor levels in patients with chronic hepatitis C